The role of SNP-loop diuretic interactions in hypertension across ethnic groups in HyperGEN
Open Access
- 1 January 2013
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 4, 304
Abstract
Blood pressure (BP) is significantly influenced by genetic factors; however, less than 3% of the BP variance has been accounted for by variants identified from genome-wide association studies (GWAS) of primarily European-descent cohorts. Other genetic influences, including gene-environment (GxE) interactions, may explain more of the unexplained variance in BP. African Americans (AA) have a higher prevalence and earlier age of onset of hypertension (HTN) as compared with European Americans (EA); responses to anti-hypertensive drugs vary across race groups. To examine potential interactions between the use of loop diuretics and HTN traits, we analyzed systolic (SBP) and diastolic (DBP) blood BP from 1,222 AA and 1,231 EA participants in the Hypertension Genetic Epidemiology Network (HyperGEN). Population-specific score tests were used to test associations of SBP and DBP, using a panel of genotyped and imputed single nucleotide polymorphisms (SNPs) for African Americans (2.9 million SNPs) and European Americans (2.3 million SNPs). Several promising loci were identified through gene-loop diuretic interactions, although no SNP reached genome-wide significance after adjustment for genomic inflation. In AA, SNPs in or near the genes NUDT12, CHL1, GRIA1, CACNB2, and PYHIN1 were identified for SBP, and SNPs near ID3 were identified for DBP. For EA, promising SNPs for SBP were identified in ESR1and for DBP in SPATS2L and EYA2. Among these SNPs, none were common across phenotypes or population groups. Biologic plausibility exists for many of the identified genes, suggesting that these are candidate genes for regulation of BP and/or anti-hypertensive drug response. The lack of genome-wide significance is understandable in this small study employing gene-drug interactions. These findings provide a set of prioritized SNPs/candidate genes for future studies in HTN. Studies in more diversified population samples may help identify previously missed variants.Keywords
This publication has 68 references indexed in Scilit:
- GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery diseaseBMC Cardiovascular Disorders, 2011
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study PopulationsPLOS ONE, 2010
- ProbABEL package for genome-wide association analysis of imputed dataBMC Bioinformatics, 2010
- GenABEL: an R library for genome-wide association analysisBioinformatics, 2007
- Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac DeathCirculation, 2007
- High Heritability of Ambulatory Blood Pressure in Families of East African DescentHypertension, 2005
- Mammalian NADH diphosphatases of the Nudix family: cloning and characterization of the human peroxisomal NUDT12 proteinBiochemical Journal, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertensionKidney International, 2002
- Familial aggregation of blood pressure in 558 adopted children.1976